What should I avoid while taking Primaquine 15mg tablets?

Take with food. Food decreases irritation. (Source: DrugBank, licensed under CC BY-NC 4.0)

Do I need a prescription for Primaquine 15mg tablets?

Primaquine 15mg tablets is classified as a Valid as a prescribable product in the UK. However, always consult a pharmacist or doctor before use. (Source: NHS dm+d)

What are the brand names for Primaquine 15mg tablets?

Primaquine 15mg tablets is the generic name. It is available under brand names including: Primaquine 15mg tablets. (Source: NHS dm+d — Actual Medicinal Products)

Primaquine 15mg tablets

Prescription only

Requires a prescription from a doctor or prescriber

Tablet

15mg

Oral

An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide.

Active ingredients:

Primaquine

ATC classificationBrowse ATC index

International classification by the WHO, grouping medicines by the organ system they act on

ATC P01BA03

Chemical classBrowse classes

Classification based on the molecule's chemical structure and properties

Check interactions for Primaquine

No active safety alerts

Official documents, adverse reaction reporting, and safety monitoring

Report a side effect

Submit a Yellow Card report to the MHRA

Safety monitoring data

Yellow Card reports

MHRA

The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.

View Drug Analysis Profile

Browse all Drug Analysis Profiles A–Z

Browse all iDAP reports

Interactive Drug Analysis Profiles for all medicines

Report a side effect

Submit a Yellow Card report to the MHRA

Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.

EudraVigilance

EMA

The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.

View EudraVigilance report

Suspected adverse reactions reported for Primaquine

About EudraVigilance

Learn about EU pharmacovigilance and safety monitoring

EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.

1 branded products available

1 productsShow details

1 products

Possibly available on the UK marketRestricted supplyDiscontinuedAvailability per NHS dm+d

MHRA licensed products

View all licensed products for Primaquine on the MHRA register

Primaquine 15mg tablets

Imported (United States)

None

Imported

Source: NHS dm+dOGL 3.0

Updated about 1 month ago(1 Mar 2026)

Therapeutically similar medicines

10 similarShow details

Hydroxychloroquine 300mg tablets

Tablet

300mg

Same therapeutic group

Hydroxychloroquine 400mg/5ml oral suspension

Oral suspension

400mg/5ml

Same therapeutic group

Primaquine 2.5mg/5ml oral suspension

Oral suspension

2.5mg/5ml

Same therapeutic group

Hydroxychloroquine 108mg/5ml oral solution

Oral solution

108mg/5ml

Same therapeutic group

Hydroxychloroquine 15mg/5ml oral solution

Oral solution

15mg/5ml

Same therapeutic group

Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.

Clinical guidelines and formulary information

British National Formulary

Primaquine

BNF

Drug monograph — bnf.nice.org.uk

Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.

Check stock at pharmacies and supply information

Show details

Pharmacy stock checkers

Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.

Boots

Search products

Click & collectNHS

Lloyds

Search products

DeliveryNHS

P2U

Pharmacy2U

Search products

DeliveryNHS

Supply & product information

Official product databases and supply status monitoring

Shortages info

NHS Specialist Pharmacy Service (SPS)

emc product search

Discontinuations & alternatives for Primaquine

Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.

Codes for healthcare professionals and prescribing systems

Show details

These codes are used by healthcare IT systems and prescribers to identify this medicine.

NHS UK identifiers

SNOMED CT

41987511000001101

dm+d ID

41987511000001101

VTM (Virtual Therapeutic Moiety)

777314009

VMP (Virtual Medicinal Product)

41987511000001101

International identifiers

ATC code — Anatomical Therapeutic Chemical (WHO)

P01BA03

Browse tools

dm+d Browser

NHSBSA medicines dictionary lookup

SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).

Active and completed clinical studies from ClinicalTrials.gov

Show details

Searching UK clinical trials...

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.

Pharmacology and chemical data from DrugBank

go.drugbank.com

Key facts

Drug status

Approved

Major interactions

None known

Half-life

3.7-7.4 hours

Mechanism

Primaquine's mechanism of action is not well understood.

Food interactions

1 warning

Human targets

2 targets

Data: DrugBank · CC BY-NC 4.0

Pharmacokinetics at a glance

Half-life

3.7-7.4 hours

3.7-7.4 hours

Pharmacokinetic data: DrugBank · CC BY-NC 4.0

Status:

Approved

Investigational

Small molecule

About this compound

An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)

Properties:

solid

Avg. mass: 259.35 Da

View FDA drug label

DrugBank indication

For the treatment of malaria.

Also known as(66)

6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline

8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline

8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline

Primachin

Primachina

Primachinum

Primaquin

Primaquina

Dosage forms(9)

Tablet (Oral) — 15 mg

Tablet, film coated (Oral) — 7.5 MG

Tablet (Oral)

Tablet, coated (Oral)

Tablet (Oral) — 26.3 mg

Tablet (Oral) — 15 mg/1

Tablet, film coated (Oral) — 15 mg/1

Tablet, film coated (Oral) — 26.3 mg/1

Molecular properties(19)

Drug interactions(1275)

Known interactions with other medications. Always consult a healthcare professional.

Deferasirox

Unknown severity

DB01609

The serum concentration of Primaquine can be increased when it is combined with Deferasirox.

Check this interaction

Peginterferon alfa-2b

Unknown severity

DB00022

The serum concentration of Primaquine can be increased when it is combined with Peginterferon alfa-2b.

Check this interaction

Leflunomide

Unknown severity

DB01097

The serum concentration of Primaquine can be decreased when it is combined with Leflunomide.

Check this interaction

Teriflunomide

Unknown severity

DB08880

The serum concentration of Primaquine can be decreased when it is combined with Teriflunomide.

Check this interaction

Brexpiprazole

Moderate

DB09128

The metabolism of Brexpiprazole can be decreased when combined with Primaquine.

Check this interaction

Eliglustat

Moderate

DB09039

The metabolism of Eliglustat can be decreased when combined with Primaquine.

Check this interaction

Everolimus

Moderate

DB01590

The metabolism of Everolimus can be decreased when combined with Primaquine.

Check this interaction

Flibanserin

Moderate

DB04908

The metabolism of Flibanserin can be decreased when combined with Primaquine.

Check this interaction

Ibrutinib

Moderate

DB09053

The metabolism of Ibrutinib can be decreased when combined with Primaquine.

Check this interaction

Ivabradine

Moderate

DB09083

The metabolism of Ivabradine can be decreased when combined with Primaquine.

Check this interaction

Ivacaftor

Moderate

DB08820

The metabolism of Ivacaftor can be decreased when combined with Primaquine.

Check this interaction

Lurasidone

Moderate

DB08815

The metabolism of Lurasidone can be decreased when combined with Primaquine.

Check this interaction

Naloxegol

Moderate

DB09049

The metabolism of Naloxegol can be decreased when combined with Primaquine.

Check this interaction

Olaparib

Moderate

DB09074

The metabolism of Olaparib can be decreased when combined with Primaquine.

Check this interaction

Ranolazine

Moderate

DB00243

The metabolism of Ranolazine can be decreased when combined with Primaquine.

Check this interaction

Sonidegib

Moderate

DB09143

The metabolism of Sonidegib can be decreased when combined with Primaquine.

Check this interaction

Avanafil

Moderate

DB06237

The metabolism of Avanafil can be decreased when combined with Primaquine.

Check this interaction

Eplerenone

Moderate

DB00700

The metabolism of Eplerenone can be decreased when combined with Primaquine.

Check this interaction

Artemether

Unknown severity

DB06697

The risk or severity of QTc prolongation can be increased when Primaquine is combined with Artemether.

Check this interaction

Lumefantrine

Unknown severity

DB06708

The risk or severity of QTc prolongation can be increased when Primaquine is combined with Lumefantrine.

Check this interaction

Cilostazol

Moderate

DB01166

The metabolism of Cilostazol can be decreased when combined with Primaquine.

Check this interaction

Colchicine

Moderate

DB01394

The metabolism of Colchicine can be decreased when combined with Primaquine.

Check this interaction

Fentanyl

Moderate

DB00813

The metabolism of Fentanyl can be decreased when combined with Primaquine.

Check this interaction

Iloperidone

Moderate

DB04946

The metabolism of Iloperidone can be decreased when combined with Primaquine.

Check this interaction

Retapamulin

Moderate

DB01256

The metabolism of Retapamulin can be decreased when combined with Primaquine.

Check this interaction

Tofacitinib

Moderate

DB08895

The metabolism of Tofacitinib can be decreased when combined with Primaquine.

Check this interaction

Vardenafil

Moderate

DB00862

The metabolism of Vardenafil can be decreased when combined with Primaquine.

Check this interaction

Eszopiclone

Moderate

DB00402

The metabolism of Eszopiclone can be decreased when combined with Primaquine.

Check this interaction

Zopiclone

Moderate

DB01198

The metabolism of Zopiclone can be decreased when combined with Primaquine.

Check this interaction

Lovastatin

Moderate

DB00227

The metabolism of Lovastatin can be decreased when combined with Primaquine.

Check this interaction

Prilocaine

Unknown severity

DB00750

The risk or severity of methemoglobinemia can be increased when Primaquine is combined with Prilocaine.

Check this interaction

Alfuzosin

Moderate

DB00346

The metabolism of Alfuzosin can be decreased when combined with Primaquine.

Check this interaction

Alprazolam

Moderate

DB00404

The metabolism of Alprazolam can be decreased when combined with Primaquine.

Check this interaction

Atomoxetine

Moderate

DB00289

The metabolism of Atomoxetine can be decreased when combined with Primaquine.

Check this interaction

Mefloquine

Unknown severity

DB00358

The risk or severity of adverse effects can be increased when Primaquine is combined with Mefloquine.

Check this interaction

Warfarin

Unknown severity

DB00682

The serum concentration of Warfarin can be increased when it is combined with Primaquine.

Check this interaction

Acenocoumarol

Unknown severity

DB01418

The serum concentration of Acenocoumarol can be increased when it is combined with Primaquine.

Check this interaction

(R)-warfarin

Unknown severity

DB08496

The serum concentration of (R)-warfarin can be increased when it is combined with Primaquine.

Check this interaction

R,S-Warfarin alcohol

Unknown severity

DB08735

The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Primaquine.

Check this interaction

S,R-Warfarin alcohol

Unknown severity

DB08736

The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Primaquine.

Check this interaction

(S)-Warfarin

Unknown severity

DB14055

The serum concentration of (S)-Warfarin can be increased when it is combined with Primaquine.

Check this interaction

Midazolam

Unknown severity

DB00683

The serum concentration of Midazolam can be increased when it is combined with Primaquine.

Check this interaction

Tacrolimus

Unknown severity

DB00864

The serum concentration of Tacrolimus can be increased when it is combined with Primaquine.

Check this interaction

Atorvastatin

Moderate

DB01076

The metabolism of Atorvastatin can be decreased when combined with Primaquine.

Check this interaction

Abiraterone

Unknown severity

DB05812

The serum concentration of Primaquine can be increased when it is combined with Abiraterone.

Check this interaction

Cyproterone acetate

Moderate

DB04839

The metabolism of Primaquine can be increased when combined with Cyproterone acetate.

Check this interaction

Thiethylperazine

Unknown severity

DB00372

The risk or severity of QTc prolongation can be increased when Primaquine is combined with Thiethylperazine.

Check this interaction

Triflupromazine

Unknown severity

DB00508

The risk or severity of QTc prolongation can be increased when Primaquine is combined with Triflupromazine.

Check this interaction

Fluphenazine

Unknown severity

DB00623

The risk or severity of QTc prolongation can be increased when Primaquine is combined with Fluphenazine.

Check this interaction

Moricizine

Unknown severity

DB00680

The risk or severity of QTc prolongation can be increased when Primaquine is combined with Moricizine.

Check this interaction

Showing 50 of 1275 interactions

Food & lifestyle interactions

Take With Food

Take with food. Food decreases irritation.

How it works

Mechanism of action

Primaquine's mechanism of action is not well understood. It may be acting by generating reactive oxygen species or by interfering with the electron transport in the parasite. Also, although its mechanism of action is unclear, primaquine may bind to and alter the properties of protozoal DNA.

Pharmacodynamics

Primaquine is an antimalarial agent and is the essential co-drug with chloroquine in treating all cases of malaria. In the blood, malaria parasites break down a part of the red blood cells known as haemoglobin. When this happens haemoglobin is divided into two parts; haem and globin. Haem is toxic to the malaria parasite. To prevent it from being damaged, the malaria parasite produces an chemical which converts the toxic haem into a non-toxic product. Primaquine acts by interfering with a part of the parasite (mitochondria) that is responsible for supplying it with energy. Without energy the parasite dies. This stops the infection from continuing and allows the person to recover. Primaquine kills the intrahepatic form of Plasmodium vivax and Plasmodium ovale, and thereby prevents the development of the erythrocytic forms that are responsible for relapses (it also kills gametocytes). Primaquine is not used in the prevention of malaria, only in the treatment. It has insignificant activity against the asexual blood forms of the parasite and therefore it is always used in conjunction with a blood schizonticide and never as a single agent. Primaquine has gametocytocidal activity against all plasmodia, including P. falciparum.

Pharmacokinetics

How the body processes this drug — absorption, distribution, metabolism, and elimination

Half-life

3.7-7.4 hours

Drug targets(2)

Proteins and enzymes this drug interacts with in the body

Keratin, type II cytoskeletal 7

BE0002459

KRT7

other/unknown

Specific functionstructural constituent of skin epidermis

Cellular location

Cytoplasm

General function & pharmacology

Blocks interferon-dependent interphase and stimulates DNA synthesis in cells. Involved in the translational regulation of the human papillomavirus type 16 E7 mRNA (HPV16 E7)

Ribosyldihydronicotinamide dehydrogenase [quinone]

BE0000220

NQO2

inhibitor

Specific functionchloride ion binding

Cellular location

Cytoplasm

General function & pharmacology

The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis

Metabolizing enzymes(5)

Enzymes involved in drug metabolism — important for understanding drug interactions

Enzyme activity key

substrate

inhibitor

inducer

CYP3A4Cytochrome P450 3A4

substrate

inhibitor

CYP1A2Cytochrome P450 1A2

substrate

inducer

CYP2D6Cytochrome P450 2D6

inhibitor

CYP1A1Cytochrome P450 1A1

inducer

CYP1B1Cytochrome P450 1B1

inducer

Transporters(1)

Proteins that transport this drug across cell membranes

ATP-dependent translocase ABCB1

BE0001032

ABCB1

inhibitor

Specific functionABC-type xenobiotic transporter activity

Cellular location

Cell membrane

General function & pharmacology

Translocates drugs and phospholipids across the membrane .
PMID:2897240 PMID:35970996 PMID:8898203 PMID:9038218 PMID:35507548

Catalyzes the flop of phospholipids from the cytoplasmic to the exoplasmic leaflet of the apical membrane. Participates mainly to the flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-glucosylceramides and sphingomyelins .
PMID:8898203
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells PMID:2897240 PMID:35970996 PMID:9038218

Scientific references(7)

Mihaly G.W., Ward S.A., Edwards G., Nicholl D.D., Orme M.L., Breckenridge A.M.

Pharmacokinetics of primaquine in man.

Studies of the absolute bioavailability and effects of dose size.. British Journal of Clinical Pharmacology. 198519(6):745-750. doi: 10.1111/j.1365-2125.1985.tb02709.x

PMID: 4027117 DOI: 10.1111/j.1365-2125.1985.tb02709.x

ALVING A.S., ARNOLD J., HOCKWALD R.S., CLAYMAN C.B., DERN R.J., BEUTLER E., FLANAGAN C.L.

Induced primaquine resistance in vivax malaria.

Transactions of the Royal Society of Tropical Medicine and Hygiene

196155(4):345-350. doi: 10.1016/0035-9203(61)90103-1

PMID: 13242948 DOI: 10.1016/0035-9203(61)90103-1

Hill D.R., Baird J.K., Parise M.E., Lewis L.S., Ryan E.T., Magill A.J.

PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I.

The American Journal of Tropical Medicine and Hygiene

200675(3):402-415. doi: 10.4269/ajtmh.2006.75.402

PMID: 16968913 DOI: 10.4269/ajtmh.2006.75.402

Cohen R.J., Sachs J.R., Wicker D.J., Conrad M.E.

Methemoglobinemia Provoked by Malarial Chemoprophylaxis in Vietnam.

New England Journal of Medicine

1968279(21):1127-1131. doi: 10.1056/nejm196811212792102

PMID: 5686480 DOI: 10.1056/nejm196811212792102

Coleman M.D., Coleman N.A.

Drug-Induced Methaemoglobinaemia Treatment Issues.

Drug Safety

199614(6):394-405. doi: 10.2165/00002018-199614060-00005

PMID: 8828017 DOI: 10.2165/00002018-199614060-00005

Taavitsainen P., Juvonen R., Pelkonen O.

Selegiline Metabolism and Cytochrome P450 Enzymes:<i>In vitro</i> Study in Human Liver Microsomes*.

Pharmacology & Toxicology

200086(5):215-221. doi: 10.1034/j.1600-0773.2000.pto860504.x

PMID: 11181487 DOI: 10.1034/j.1600-0773.2000.pto860504.x

Bapiro T.E., Andersson T.B., Otter C., Hasler J.A., Masimirembwa C.M.

Cytochrome P 450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells.

European Journal of Clinical Pharmacology

200258(8):537-542. doi: 10.1007/s00228-002-0512-z

PMID: 12451431 DOI: 10.1007/s00228-002-0512-z

ATC classification(1 code)

ATC P01BA03

Affected organisms(1)

Plasmodium

International brands(2)

Salt forms(1)

Primaquine phosphate(DBSALT001188)

Experimental properties(3)

External resources(1)

Drugs.com

Commercial products(15)

Chemical identifiers

CAS, UNII, InChI Key and database cross-references

Show

Linked compound data from DrugBank Open Data (CC BY-NC 4.0)

Primaquine

DB01087

CAS number

90-34-6

UNII (FDA)

MVR3634GX1

InChI Key (molecular fingerprint)

INDBQLZJXZLFIT-UHFFFAOYSA-N

Additional database identifiers

Drugs Product Database (DPD)

3336

ChEBI

8405

PubChem Compound

4908

PubChem Substance

46508222

KEGG Compound

C07627

ChemSpider

4739

BindingDB

71542

PharmGKB

PA451103

Therapeutic Targets Database

DAP000216

Wikipedia

Primaquine

ChEMBL

CHEMBL506

RxCUI

8687

HUGO Gene Nomenclature Committee (HGNC)

HGNC:6445

GenAtlas

KRT7

GeneCards

KRT7

GenBank Gene Database

AJ238246

UniProtKB

P08729

UniProt Accession

K2C7_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:7856

GenAtlas

NQO2

GeneCards

NQO2

GenBank Gene Database

J02888

GenBank Protein Database

190818

UniProtKB

P16083

UniProt Accession

NQO2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2637

GenAtlas

CYP3A4

GeneCards

CYP3A4

GenBank Gene Database

M18907

Guide to Pharmacology

1337

UniProtKB

P08684

UniProt Accession

CP3A4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2596

GenAtlas

CYP1A2

GeneCards

CYP1A2

GenBank Gene Database

Z00036

Guide to Pharmacology

1319

UniProtKB

P05177

UniProt Accession

CP1A2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2625

GenAtlas

CYP2D6

GeneCards

CYP2D6

GenBank Gene Database

M20403

GenBank Protein Database

181350

Guide to Pharmacology

1329

UniProtKB

P10635

UniProt Accession

CP2D6_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2595

GeneCards

CYP1A1

GenBank Gene Database

K03191

GenBank Protein Database

181276

Guide to Pharmacology

1318

UniProtKB

P04798

UniProt Accession

CP1A1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2597

GenAtlas

CYP1B1

GeneCards

CYP1B1

GenBank Gene Database

U03688

GenBank Protein Database

501031

Guide to Pharmacology

1320

UniProtKB

Q16678

UniProt Accession

CP1B1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:40

GenAtlas

ABCB1

GeneCards

ABCB1

GenBank Gene Database

M14758

GenBank Protein Database

307180

Guide to Pharmacology

768

UniProtKB

P08183

UniProt Accession

MDR1_HUMAN

International reference pricing

3 formulations

Reference pricing from DrugBank. Prices are indicative and may not reflect current UK costs.

From $0.43/tablet

To $18.20/g

Primaquine Phosphate 15 mg Tablet

$0.43/tablet

Primaquine 26.3 mg tablet

$1.51/tablet

Primaquin phosphate powder

$18.20/g

Source: DrugBank. Used under CC BY-NC 4.0 academic licence for non-commercial purposes.

DrugBank citations

If you use DrugBank data in your research, please cite the following publications:

Knox C., Wilson M., Klinger C.M., et al

DrugBank 6.

0: the DrugBank Knowledgebase for 2024

Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275

PMID: 37953279

Wishart D.S., Feunang Y.D., Guo A.C., et al

DrugBank 5.

0: a major update to the DrugBank database for 2018

Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082

PMID: 29126136

Show earlier publications

Law V., Knox C., Djoumbou Y., et al

DrugBank 4.

0: shedding new light on drug metabolism

Nucleic Acids Res. 2014 Jan 142(1):D1091-7

PMID: 24203711

Knox C., Law V., Jewison T., et al

DrugBank 3.

0: a comprehensive resource for 'omics' research on drugs

Nucleic Acids Res. 2011 Jan39(Database issue):D1035-41

PMID: 21059682

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Nucleic Acids Research

2008 Jan36(Database issue):D901-6

PMID: 18048412

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Nucleic Acids Research

2006 Jan 134(Database issue):D668-72

PMID: 16381955

Source: go.drugbank.comCC BY-NC 4.0

Updated 27 days ago(8 Mar 2026)

Back to medicines

Primaquine 15mg tablets

Safety monitoring data

Yellow Card reports

EudraVigilance

British National Formulary

Pharmacy stock checkers

Supply & product information

NHS UK identifiers

International identifiers

Browse tools

Key facts

Pharmacokinetics at a glance

Half-life

Clinical essentials

Pharmacology

Deep science
8

Chemical identifiers

Primaquine

Additional database identifiers

International reference pricing

DrugBank citations

Primaquine 15mg tablets

Safety & regulatory

Safety monitoring data

Yellow Card reports

EudraVigilance

Brand versions and licensed products

Medicines like this

Guidance (NICE / BNF)

British National Formulary

Availability, stocks & shortages

Pharmacy stock checkers

Supply & product information

Professional identifiers

NHS UK identifiers

International identifiers

Browse tools

Clinical trials

DrugBank data

Key facts

Pharmacokinetics at a glance

Half-life

Clinical essentials

Pharmacology

Deep science8

Chemical identifiers

Primaquine

Additional database identifiers

International reference pricing

DrugBank citations

Deep science
8